Hostname: page-component-745bb68f8f-mzp66 Total loading time: 0 Render date: 2025-01-23T21:11:46.711Z Has data issue: false hasContentIssue false
  • English
  • Français

Seven Cases of Gilles de la Tourette's Syndrome: Partial Relief with Clonazepam: A Pilot Study

Published online by Cambridge University Press:  18 September 2015

M. Gonce  and
A. Barbeau
M. Gonce
Affiliation:
Department of Neurobiology, Clinical Research Institute of Montreal
A. Barbeau*
Affiliation:
Department of Neurobiology, Clinical Research Institute of Montreal
*
Department of Neurobiology, Clinical Research Institute of Montreal, 110 Pine Avenue West, Montreal, Quebec H2W 1R7
Rights & Permissions [Opens in a new window]

Summary:

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

The histories of seven consecutive cases of Gilles de la Tourette's syndrome are presented to exemplify the range of clinical manifestations in this disease and to collate preliminary results with the new benzodiazepine, clonazepam, as a possible adjuvant therapy of this disorder. Controlled trials with clonazepam alone and in association with haloperidol are now justified. Five of our 7 patients had a positive family history of tics, and 2 a confirmed family history of gout. Because clonazepam improves myoclonia and tics and because its mechanism of action possibly involves serotonin, we thought it worthwhile to study simultaneously the relative roles of serotonin and dopamine metabolism in the production of tics, and their relationship to possible defects in purine metabolism in Gilles de la Tourette's syndrome.

Type
Research Article
Information
Canadian Journal of Neurological Sciences , Volume 4 , Issue 4 , November 1977 , pp. 279 - 283
Copyright
Copyright © Canadian Neurological Sciences Federation 1977

References

REFERENCES

Abuzzahab, F.S. and Anderson, F.O. (1974). Gilles de la Tourette’s syndrome: Cross-cultural analysis and treatment outcome. Clin. Neurol. Neurosurg.. 1. 66–74.CrossRefGoogle Scholar
Abuzzahab, F.S.. Anderson, F.O. and Sekhov, S.M. (1975). Multiple tic disorder: Gilles de la Tourette’s syndrome. Practical Psychology for Physician, 2, 58–60.Google Scholar
Abazzahab, F.S. and Ehlen, K.J. (1971). The clinical picture and management of Gilles de la Tourette’s syndrome. Child Psychiatry and Human Development, 2, 14–25.CrossRefGoogle Scholar
Ascher, E. (1948). Psychodynamic considerations in Gilles de la Tourette’s disease (maladie des tics). American Journal of Psychiatry, 105. 267–276.CrossRefGoogle ScholarPubMed
Barbeau, A. (1962). The pathogenesis of Parkinson’s disease: A new hypothesis. Canadian Medical Association Journal. 87. 802–807.Google ScholarPubMed
Barbeau, A. (1975). Maladies du systéme extrapyramidal. In: (Pequignot, H., ed.). Pathologie Médicale. Masson Cie, Paris, pp. 1446–1453.Google Scholar
Bourdouresque, J., Roger, J., Khalil, R., Virouroux, R.A.Gosset, A., Pelliser, J.F. and Tassinari, C.A. (1971). La maladie de Gilles de la Tourelte. Revue Neurologique. 125. 306–309.Google Scholar
Browne, R.D. (1976). Clonazepam. A review of a new anticonvulsant drug. Archives of Neurology. 33. 326–332.CrossRefGoogle ScholarPubMed
Bruun, R.D. and Shapiro, A.K. (1972). Differential diagnosis of Gilles de la Tourette’s syndrome. Journal of Nervous and Mental Diseases, 155, 328–334.CrossRefGoogle ScholarPubMed
Chadwick, D., Harris, R., Jenner, P., Reynolds, E.H. and Marsden, C.D. (1975). Manipulation of brain serotonin in the treatment of myoclonus. Lancet, 1, 434–435, 1975.CrossRefGoogle Scholar
Chapel, J.L., Brown, N. and Jenkins, R.L. (1964). Tourette’s disease: Symptomatic relief with haloperidol. American Journal of Psychiatry, 121, 608–610.CrossRefGoogle ScholarPubMed
Cohen, D.J., Shaywitz, B.A., Johnson, W.T. and Bowers, R. Jr. (1974). Biogenic amines in autistic and atypical children. Archives of General Psychiatry, 31, 845–853.CrossRefGoogle ScholarPubMed
Corbett, J.A., Matthews, A.M., Connell, P.H. and Shapiro, D.A. (1969). Tics and GTS: A follow-up study and critical review. British Journal of Psychiatry, 115. 1229–1241.CrossRefGoogle Scholar
Corbin, K.B. (1970). GTS: Common neurophysiologic factors reported in literature. New York State Journal of Medicine, 70, 2193–2197.Google Scholar
Digiacomo, J.N., Fahn, S., Glass, J.B. and Westlake, R.J. (1971). A case with GTS treated with haloperidol and unsuccessful treatment with L-Dopa. Journal of Nervous and Mental Diseases, 152, 115–117.Google Scholar
Fennessy, M.R. and Lee, J.R. (1972). The effect of benzodiazepines on brain amines of the mouse. Archives Internationales de Pharmacodynamie et de Thérapie, 197, 37–44.Google ScholarPubMed
Fernando, S.J.M. (1976). Six cases of Gilles de la Tourette’s syndrome. British Journal of Psychiatry. 128. 436–441.CrossRefGoogle ScholarPubMed
Friel, P.B. (1973). Familial incidence of Gilles de la Tourette’s disease. British Journal of Psychiatry. 112. 655–658.CrossRefGoogle Scholar
Goldberg, M.A. and Dorman, J.D. (1976). Intention myoclonus: successful treatment with clonazepam. Neurology. 26. 24–26.CrossRefGoogle Scholar
Golden, G.S. (1976). Tourette’s syndrome and central nervous system stimulants. Presented at the 28th Annual Meeting of the American Academy of Neurology. April 26-May 1. 1976.Google Scholar
Gonce, M. and Barbeau, A. (1977). La maladie de Gilles de la Tourette. Union Médicale du Canada. 106. 559–570.Google Scholar
Jenner, P., Chadwick, D., Reynolds, E.H. and Marsden, C.D. (1975). Altered 5-HT metabolism with clonazepam, diazepam and diphenylhydantoin. Journal of Pharmacy and Pharmacology. 27. 707–710.CrossRefGoogle ScholarPubMed
L’hermitte, F., Peterfalvi, M. and Marteau, R. (1971). Analyse pharmacologique d’un cas de myoclonies d’intention et d’action post-anoxiques. Revue Neurologique. 124. 21–31.Google Scholar
Lucas, A.R. (1973). Report of GT’s disease in two succeeding generations. Child Psychiatry Human Development. 3. 321–323.CrossRefGoogle Scholar
Mizumo, T. and Yugari, Y. (1974), Self-mutilation in Lesch-Nyhan syndrome. Lancet, Vol T: 761.CrossRefGoogle Scholar
Moldofsky, H. (1971). A psychophysiological study of multiple tics. Archives of General Psychiatry, 25, 79–87.CrossRefGoogle ScholarPubMed
Moldofsky, H., Tullis, C. and Lamon, R. (1974). Multiple tic syndrome (Gilles de la Tourette’s syndrome). Journal of Nervous and Mental Diseases. 159, 252–292.CrossRefGoogle Scholar
Nyhan, W.L. (1972). Clinical features of the Lesh-Nyhan syndrome. Archives of Internal Medicine. 130. 186–192.CrossRefGoogle Scholar
Pfeiffer, C.C.Iliev, V., Nichols, R.E. and Sugerman, A.A. (1969). The serum urate level reflects degrees of stress. Journal of Clinical Pharmacology, 9. 384–392.Google ScholarPubMed
Salmi, K. (1961). Gilles de la Tourette’s disease: The report of a case and its treatment. Acta Psychiatrica et Neurologica Scandinavica, 36, 157–162.CrossRefGoogle ScholarPubMed
Sanders, D.G. (1973). Familial occurrence of GTS. Archives of General Psychiatry, 28. 326–328.CrossRefGoogle Scholar
Seegmiller, J.G. (1968). The discussion of pathology and pathologic physiology of Lesch-Nyhan syndrome. Federation Proceedings. 27, 1044–1046.Google Scholar
Seignot, J.N. (1961). Un cas de maladie des tics de Gilles de la Tourette guéri par le R-1625. Annales Médico-Psychologiques. 119. 578.Google Scholar
Shapiro, A.K., Shapiro, E. and Wayne, H. (1973). Treatment of Tourette’s syndrome with haloperidol. Review of 34 cases. Archives of General Psychiatry. 28. 92–97.CrossRefGoogle ScholarPubMed
Shapiro, A.K., Shapiro, E. and Wayne, H.L. (1973). The symptomatology and diagnosis of Gilles de la Tourette’s syndrome. Journal of The American Academy of Child Psychiatry, 12. 702–723.CrossRefGoogle ScholarPubMed
Sweet, R.D., Bruun, R.D., Shapiro, A.K. and Shapiro, E. (1976) The pharmacology of Gilles de la Tourette’s syndrome (chronic multiple tic). In: (Klawans, H.L.. ed.). Clinical Neuropharmacology. Raven Press. New York. pp. 81–105.Google Scholar
Van Woert, M.H.. Jutkowitz, R., Rosenbaum, D. and Bowers, M.B. Jr. (1976). In: (Yahr, M.D.. ed.). The Basal Ganglia: Association for Research in Nervous and Mental Disease. Vol. 55. Raven Press. New York. pp. 459–465.Google Scholar
Van Woert, M.H. and Sethy, V.H. (1975). Therapy of intention myoclonus with L-5-hydroxytryptophan and a peripheral decarboxylase inhibition. MK-486. Neurology. 25. 135–140.CrossRefGoogle Scholar
Van Woert, M.H. and Sethy, V.H. (1975). Therapy of myoclonus with L-5-hydroxytryptophan plus MK-486. Neurology. 25. 362.CrossRefGoogle Scholar
Woodrow, K.M. (1974). Gilles de la Tourette’s disease. A review. American Journal of Psychiatry. 131. 1000–1003.CrossRefGoogle Scholar